Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allovir, Inc. | Chief Scientific Officer | Common Stock | 124K | $83.2K | $0.67 | Feb 2, 2023 | Direct |
Allovir, Inc. | Chief Scientific Officer | Stock Option (Right to Buy) | 474K | Feb 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALVR | Allovir, Inc. | Aug 16, 2022 | 1 | $0 | 4 | Aug 17, 2022 | Chief Scientific Officer |
ALVR | Allovir, Inc. | Jan 18, 2022 | 6 | $0 | 4 | Feb 3, 2023 | Chief Scientific Officer |
ALVR | Allovir, Inc. | Nov 12, 2021 | 4 | -$466K | 4 | Nov 16, 2021 | Chief Scientific Officer |
ALVR | Allovir, Inc. | May 10, 2021 | 1 | -$3.41M | 4 | May 10, 2021 | Chief Scientific Officer |